Medline Inc Cl A (MDLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||
| Net Income | 239,000 | N/A | 322,000 |
| Depreciation Amortization | 265,000 | N/A | 262,000 |
| Income taxes - deferred | 37,000 | N/A | -4,000 |
| Accounts receivable | -146,000 | N/A | -98,000 |
| Accounts payable and accrued liabilities | 6,000 | N/A | 35,000 |
| Other Working Capital | -161,000 | N/A | 5,000 |
| Other Operating Activity | 172,000 | 0 | 160,000 |
| Operating Cash Flow | $412,000 | $N/A | $682,000 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -96,000 | N/A | -98,000 |
| Net Acquisitions | N/A | N/A | 6,000 |
| Investing Cash Flow | $-96,000 | $N/A | $-92,000 |
| Cash Flows From Financing Activities | |||
| Change In Short Term Borrowing | N/A | N/A | 179,000 |
| Common Stock Repurchased | N/A | N/A | -9,000 |
| Other Financing Activity | -13,000 | 0 | -179,000 |
| Financing Cash Flow | $-13,000 | $N/A | $-9,000 |
| Exchange Rate Effect | -7,000 | N/A | 9,000 |
| Beginning Cash Position | 1,942,000 | N/A | 250,000 |
| End Cash Position | 2,238,000 | N/A | 840,000 |
| Net Cash Flow | $296,000 | $N/A | $590,000 |
| Free Cash Flow | |||
| Operating Cash Flow | 412,000 | N/A | 682,000 |
| Capital Expenditure | -96,000 | N/A | -98,000 |
| Free Cash Flow | 316,000 | 0 | 584,000 |